FdaApplication
NDA 215875
Identifiers
- fda_app_no: NDA215875
Properties
| Property | Value |
|---|---|
| applicant_name | PH HEALTH LTD |
| application_type | NDA |
| approval_date | 2023-04-21 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADRENALIN | EPINEPHRINE | 2MG/250ML (8MCG/ML) | SOLUTION;INTRAVENOUS |
| ADRENALIN | EPINEPHRINE | 8MG/250ML (32MCG/ML) | SOLUTION;INTRAVENOUS |
| ADRENALIN | EPINEPHRINE | 10MG/250ML (40MCG/ML) | SOLUTION;INTRAVENOUS |
| ADRENALIN | EPINEPHRINE | 4MG/250ML (16MCG/ML) | SOLUTION;INTRAVENOUS |
| ADRENALIN | EPINEPHRINE | 5MG/250ML (20MCG/ML) | SOLUTION;INTRAVENOUS |
5 products